Afficher la notice abrégée

Use of partially hydrolysed formula in infancy and incidence of eczema, respiratory symptoms or food allergies in toddlers from the ELFE cohort

dc.rights.licenseopenen_US
dc.contributor.authorDAVISSE-PATURET, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON-SEMJEN, Chantal
dc.contributor.authorADEL-PATIENT, K.
dc.contributor.authorDIVARET-CHAUVEAU, A.
dc.contributor.authorBOIS, C.
dc.contributor.authorDUFOURG, M. N.
dc.contributor.authorLIORET, S.
dc.contributor.authorCHARLES, M. A.
dc.contributor.authorDE LAUZON-GUILLAIN, B.
dc.date.accessioned2020-06-17T10:24:18Z
dc.date.available2020-06-17T10:24:18Z
dc.date.issued2019-09
dc.identifier.issn1399-3038 (Electronic) 0905-6157 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/7972
dc.description.abstractEnBACKGROUND AND OBJECTIVES: Partially hydrolysed formulas (pHF) are recommended in non-breastfed infants with familial history of allergy to prevent allergy development. However, recent meta-analysis does not provide strong support for their protective effect. The present work assesses the links between 2-month infant formula use and the incidence of eczema, respiratory symptoms or food allergies (FA) up to 2 years of age. METHODS: The nationwide ELFE birth cohort is a population-based study from mainland France. Infant feeding (breast milk only, partially-hydrolysed formula with (pHF-HA) or without a hypoallergenic label (pHF-non-HA) and non-hydrolysed formula (nHF)) was reported at 2 months. Eczema, FA and respiratory symptoms such as wheezing and asthma were reported at 2 months, 1 year and 2 years. Infant with prior FA at 2 months were excluded from analyses. RESULTS: Among 11,720 infants, those who received only breast milk at 2 months were at lower risk of eczema at 1 year than those who received nHF (OR[95% CI]=0.78[0.65-0.94] in non-at-risk infants; 0.86[0.75-0.98] in at-risk infants). The use of pHF-HA, compared with nHF, at 2 months was related to higher risk of wheezing at 1 year in at-risk infants (1.68[1.24-2.28]), and higher risk of FA at 2 years both in non-at-risk infants (3.78[1.52-9.41]) and in at-risk infants (2.31[1.36-3.94]). CONCLUSIONS: In this nationwide study, pHF-HA use was not associated with a lower risk of any of the studied outcomes. Quite the reverse, it was associated with a higher risk of wheezing and FA. This should be confirmed in further studies. This article is protected by copyright. All rights reserved.
dc.language.isoENen_US
dc.subject.enEPICENE
dc.title.enUse of partially hydrolysed formula in infancy and incidence of eczema, respiratory symptoms or food allergies in toddlers from the ELFE cohort
dc.title.alternativePediatr Allergy Immunolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/pai.13094en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31206800en_US
bordeaux.journalPediatr Allergy Immunolen_US
bordeaux.page614-623en_US
bordeaux.volume30en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue6en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Pediatr%20Allergy%20Immunol&rft.date=2019-09&rft.volume=30&rft.issue=6&rft.spage=614-623&rft.epage=614-623&rft.eissn=1399-3038%20(Electronic)%200905-6157%20(Linking)&rft.issn=1399-3038%20(Electronic)%200905-6157%20(Linking)&rft.au=DAVISSE-PATURET,%20C.&RAHERISON-SEMJEN,%20Chantal&ADEL-PATIENT,%20K.&DIVARET-CHAUVEAU,%20A.&BOIS,%20C.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée